• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
JAK1 Inhibition Blocks Lethal Immune Hypersensitivity in a Mouse Model of Down Syndrome.JAK1 抑制在唐氏综合征小鼠模型中阻止致命的免疫过敏反应。
Cell Rep. 2020 Nov 17;33(7):108407. doi: 10.1016/j.celrep.2020.108407.
2
COVID-19 as a mediator of interferon deficiency and hyperinflammation: Rationale for the use of JAK1/2 inhibitors in combination with interferon.COVID-19 作为干扰素缺乏和炎症过度活跃的中介:联合使用 JAK1/2 抑制剂与干扰素的原理。
Cytokine Growth Factor Rev. 2021 Aug;60:28-45. doi: 10.1016/j.cytogfr.2021.03.006. Epub 2021 Apr 14.
3
Selective Janus Kinase 1 Inhibition Is a Promising Therapeutic Approach for Lupus Erythematosus Skin Lesions.选择性 Janus 激酶 1 抑制是治疗红斑狼疮皮肤损伤的一种有前途的治疗方法。
Front Immunol. 2020 Mar 3;11:344. doi: 10.3389/fimmu.2020.00344. eCollection 2020.
4
JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies.巴瑞替尼治疗自身炎症性干扰素病的 JAK1/2 抑制作用。
J Clin Invest. 2018 Jul 2;128(7):3041-3052. doi: 10.1172/JCI98814. Epub 2018 Jun 11.
5
Janus kinase 1/2 inhibition for the treatment of autoinflammation associated with heterozygous TNFAIP3 mutation.抑制Janus激酶1/2治疗与杂合性TNFAIP3突变相关的自身炎症
J Allergy Clin Immunol. 2019 Sep;144(3):863-866.e5. doi: 10.1016/j.jaci.2019.05.026. Epub 2019 Jun 5.
6
Expression of interferon-γ, interferon-α and related genes in individuals with Down syndrome and periodontitis.干扰素-γ、干扰素-α 及相关基因在唐氏综合征伴牙周炎患者中的表达。
Cytokine. 2012 Dec;60(3):875-81. doi: 10.1016/j.cyto.2012.08.020. Epub 2012 Sep 18.
7
Mass Cytometry Reveals Global Immune Remodeling with Multi-lineage Hypersensitivity to Type I Interferon in Down Syndrome.质谱细胞术揭示唐氏综合征中 I 型干扰素的多谱系高敏感性导致的全身免疫重塑。
Cell Rep. 2019 Nov 12;29(7):1893-1908.e4. doi: 10.1016/j.celrep.2019.10.038.
8
Trisomy 21 dysregulates T cell lineages toward an autoimmunity-prone state associated with interferon hyperactivity.21 三体综合征使 T 细胞谱系向与干扰素过度活跃相关的自身免疫倾向状态失调。
Proc Natl Acad Sci U S A. 2019 Nov 26;116(48):24231-24241. doi: 10.1073/pnas.1908129116. Epub 2019 Nov 7.
9
JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial.巴瑞替尼对糖尿病肾病的 JAK1/JAK2 抑制作用:一项 2 期随机对照临床试验结果。
Nephrol Dial Transplant. 2018 Nov 1;33(11):1950-1959. doi: 10.1093/ndt/gfx377.
10
A Jak1/2 inhibitor, baricitinib, inhibits osteoclastogenesis by suppressing RANKL expression in osteoblasts in vitro.一种Jak1/2抑制剂,巴瑞替尼,在体外通过抑制成骨细胞中RANKL的表达来抑制破骨细胞生成。
PLoS One. 2017 Jul 14;12(7):e0181126. doi: 10.1371/journal.pone.0181126. eCollection 2017.

引用本文的文献

1
Interferon signaling modulates Down syndrome-associated Alzheimer's disease pathology in a mouse model.干扰素信号传导调节小鼠模型中唐氏综合征相关的阿尔茨海默病病理。
iScience. 2025 Jul 16;28(8):113130. doi: 10.1016/j.isci.2025.113130. eCollection 2025 Aug 15.
2
Experimental and clinical tests of FDA-approved kinase inhibitors for the treatment of neurological disorders (update 2024).美国食品药品监督管理局(FDA)批准的用于治疗神经疾病的激酶抑制剂的实验和临床测试(2024年更新)
Explor Drug Sci. 2025;3. doi: 10.37349/eds.2025.1008116. Epub 2025 Jul 1.
3
DYRK1A in blood and immune function: implications in leukemia, inflammatory disorders, infection and Down syndrome.血液中的DYRK1A与免疫功能:对白血病、炎症性疾病、感染及唐氏综合征的影响
Front Cell Dev Biol. 2025 May 30;13:1587089. doi: 10.3389/fcell.2025.1587089. eCollection 2025.
4
Altered Hepatic Metabolism in Down Syndrome.唐氏综合征患者肝脏代谢的改变
bioRxiv. 2025 May 31:2025.05.27.656393. doi: 10.1101/2025.05.27.656393.
5
NF-κB signaling directs a program of transient amplifications at innate immune response genes.核因子κB信号传导指导先天性免疫反应基因的瞬时扩增程序。
bioRxiv. 2025 Mar 13:2025.03.11.641929. doi: 10.1101/2025.03.11.641929.
6
Mediator kinase inhibition suppresses hyperactive interferon signaling in Down syndrome.介质激酶抑制可抑制唐氏综合征中过度活跃的干扰素信号传导。
Elife. 2025 Feb 10;13:RP100197. doi: 10.7554/eLife.100197.
7
Therapeutic JAK inhibition does not impact lung injury during viral or bacterial pneumonia in male mice.在雄性小鼠的病毒性或细菌性肺炎期间,治疗性JAK抑制不会影响肺损伤。
Physiol Rep. 2025 Feb;13(3):e70232. doi: 10.14814/phy2.70232.
8
JAK inhibition decreases the autoimmune burden in Down syndrome.JAK抑制可减轻唐氏综合征中的自身免疫负担。
Elife. 2024 Dec 31;13:RP99323. doi: 10.7554/eLife.99323.
9
Multimodal analysis of dysregulated heme metabolism, hypoxic signaling, and stress erythropoiesis in Down syndrome.唐氏综合征中失调的血红素代谢、缺氧信号和应激性红细胞生成的多模态分析。
Cell Rep. 2024 Aug 27;43(8):114599. doi: 10.1016/j.celrep.2024.114599. Epub 2024 Aug 8.
10
JAK inhibition decreases the autoimmune burden in Down syndrome.JAK抑制可减轻唐氏综合征中的自身免疫负担。
medRxiv. 2024 Oct 16:2024.06.13.24308783. doi: 10.1101/2024.06.13.24308783.

本文引用的文献

1
COVID-19 Mortality Risk in Down Syndrome: Results From a Cohort Study of 8 Million Adults.唐氏综合征患者的新冠病毒病死亡风险:一项针对800万成年人的队列研究结果
Ann Intern Med. 2021 Apr;174(4):572-576. doi: 10.7326/M20-4986. Epub 2020 Oct 21.
2
Clinical characteristics of individuals with Down syndrome deceased with CoVID-19 in Italy-A case series.意大利死于 COVID-19 的唐氏综合征个体的临床特征:一项病例系列研究。
Am J Med Genet A. 2020 Dec;182(12):2964-2970. doi: 10.1002/ajmg.a.61867. Epub 2020 Sep 12.
3
Down Syndrome and COVID-19: A Perfect Storm?唐氏综合征与 COVID-19:完美风暴?
Cell Rep Med. 2020 May 19;1(2):100019. doi: 10.1016/j.xcrm.2020.100019. Epub 2020 May 1.
4
Are patients with Down syndrome vulnerable to life-threatening COVID-19?唐氏综合征患者是否易感染危及生命的 COVID-19?
Acta Neurol Belg. 2021 Jun;121(3):685-687. doi: 10.1007/s13760-020-01373-8. Epub 2020 May 22.
5
COVID-19: Abnormal liver function tests.COVID-19:肝功能异常。
J Hepatol. 2020 Sep;73(3):566-574. doi: 10.1016/j.jhep.2020.04.006. Epub 2020 Apr 13.
6
COVID-19: consider cytokine storm syndromes and immunosuppression.2019冠状病毒病:考虑细胞因子风暴综合征和免疫抑制。
Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.
7
Liver injury in COVID-19: management and challenges.新型冠状病毒肺炎中的肝损伤:管理与挑战
Lancet Gastroenterol Hepatol. 2020 May;5(5):428-430. doi: 10.1016/S2468-1253(20)30057-1. Epub 2020 Mar 4.
8
Down syndrome.唐氏综合征。
Nat Rev Dis Primers. 2020 Feb 6;6(1):9. doi: 10.1038/s41572-019-0143-7.
9
Early Hyperbilirubinemia in Neonates with Down Syndrome.唐氏综合征新生儿的早期高胆红素血症。
J Pediatr. 2020 Apr;219:140-145. doi: 10.1016/j.jpeds.2019.12.039. Epub 2020 Jan 31.
10
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.

JAK1 抑制在唐氏综合征小鼠模型中阻止致命的免疫过敏反应。

JAK1 Inhibition Blocks Lethal Immune Hypersensitivity in a Mouse Model of Down Syndrome.

机构信息

Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.

Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.

出版信息

Cell Rep. 2020 Nov 17;33(7):108407. doi: 10.1016/j.celrep.2020.108407.

DOI:10.1016/j.celrep.2020.108407
PMID:33207208
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7727402/
Abstract

Individuals with Down syndrome (DS; trisomy 21) display hyperactivation of interferon (IFN) signaling and chronic inflammation, which could potentially be explained by the extra copy of four IFN receptor (IFNR) genes encoded on chromosome 21. However, the clinical effects of IFN hyperactivity in DS remain undefined. Here, we report that a commonly used mouse model of DS overexpresses IFNR genes and shows hypersensitivity to IFN ligands in diverse immune cell types. When treated repeatedly with a TLR3 agonist to induce chronic inflammation, these animals overexpress key IFN-stimulated genes, induce cytokine production, exhibit liver pathology, and undergo rapid weight loss. Importantly, the lethal immune hypersensitivity and cytokine production and the ensuing pathology are ameliorated by JAK1 inhibition. These results indicate that individuals with DS may experience harmful hyperinflammation upon IFN-inducing immune stimuli, as observed during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, pointing to JAK1 inhibition as a strategy to restore immune homeostasis in DS.

摘要

唐氏综合征(DS;21 三体)患者表现出干扰素(IFN)信号的过度激活和慢性炎症,这可能可以通过 21 号染色体上额外的四个 IFN 受体(IFNR)基因拷贝来解释。然而,DS 中 IFN 过度活跃的临床影响仍未定义。在这里,我们报告说,一种常用的 DS 小鼠模型过度表达 IFNR 基因,并在各种免疫细胞类型中对 IFN 配体表现出超敏反应。当用 TLR3 激动剂反复处理以诱导慢性炎症时,这些动物过度表达关键的 IFN 刺激基因,诱导细胞因子产生,表现出肝病理,并迅速体重减轻。重要的是,通过 JAK1 抑制可以改善致命的免疫过敏和细胞因子产生以及随之而来的病理。这些结果表明,DS 患者在受到 IFN 诱导的免疫刺激时可能会经历有害的过度炎症,如在严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染期间观察到的那样,这表明 JAK1 抑制是恢复 DS 中免疫稳态的一种策略。